Trial · NCT02971254
The Effects of Inhalational Anaesthetics in Cognitive Functions in Down Syndrome Patients
NCT02971254, Phase 2, Completed, Asklepieion Voulas General Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. The Effects of Inhalational Anaesthetics in Cognitive Functions in Down Syndrome Patients. Trials, record NCT02971254. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02971254
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Effects of Inhalational Anaesthetics in Cognitive Functions in Down Syndrome Patients
- NCT number
- NCT02971254
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 39 participants, actual
- Lead sponsor
- Asklepieion Voulas General Hospital
- Conditions
- Down Syndrome
- Interventions
- Sevoflurane, Desflurane
- First posted
- 2016-11-22
- Last updated
- 2020-06-09
Source ClinicalTrials.gov
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Cognitive Functions | Baseline (12 to 24 hours before surgery), 1,5 hours after surgery and 4 hours after surgery | Quantitative result measured by Prudhoe Cognitive Function Test (PCFT), a scale to assess cognitive function in adults with Down's syndrome. |
| Secondary | Spontaneous breathing | Interval between discontinuation of inhaled agent and first spontaneous breath and up to 1 hour. | |
| Secondary | Eye opening | Interval between discontinuation of inhaled agent and first eye opening and up to 1 hour. | |
| Secondary | Extubation | Interval between discontinuation of inhaled agent and extubation and up to 1 hour. | |
| Secondary | Orientation | Interval between discontinuation of inhaled agent and orientation in place, time, people and up to 1 hour. | |
| Secondary | Respond to commands | Interval between discontinuation of inhaled agent and respond to commands and up to 1 hour. | |
| Secondary | modified Aldrete Scoring System (mASS) | Interval between entrance in Post Operative Care Unit (PACU) and fulfillment of the criteria mASS to discharge PACU and up to 2 hours. | |
| Secondary | Orientation in PACU | 30 minutes after PACU entrance | Orientation in place, time and people in Post Operative Care Unit (PACU). |
| Secondary | Orientation in PACU | 60 minutes after PACU entrance | Orientation in place, time and people in Post Operative Care Unit (PACU). |
| Secondary | Antiemetics necessity. | Interval between entrance in PACU and administer antiemetic medication and up to 4 hours. | Note if additional antiemetics was needed up to 4 hours postoperatively. |
1 to 10 of 16Source ClinicalTrials.gov
See all 16 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 34535086 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02971254
GET https://conductscience.org/api/trials/v1/NCT02971254/registered